Efficacy and safety of leflunomide (LEF) versus methotrexate (MTX) in the treatment of pediatric patients with juvenile rheumatoid arthritis (JRA).

被引：0
|
作者：
Silverman, E
Spiegel, L
Jung, LK
Saurenmann, RK
Lahdenne, P
Szer, IS
Strand, V
机构：
[1] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] Creighton Univ, Med Ctr, Omaha, NE USA
[3] Univ Zurich, Childrens Hosp, Zurich, Switzerland
[4] Hosp Children & Adolescents, Helsinki, Finland
[5] Childrens Hosp, San Diego, CA USA
[6] Stanford Univ, Palo Alto, CA 94304 USA
来源：
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3654 / 3654
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of leflunomide (LEF) versus methotrexate (MTX) in the treatment of pediatric patients with juvenile rheumatoid arthritis
    Silverman, E
    Prieur, A
    Spiegel, L
    Jung, LK
    Saurenmann, RK
    Lahdenne, PO
    Szer, IS
    Simpson, K
    Stewart, J
    Strand, V
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 195 - 195
  • [2] Durability of efficacy, safety, and tolerability of leflunomide (LEF) or methotrexate (MTX) over 48 weeks of treatment in pediatric patients with juvenile rheumatoid arthritis (JRA)
    Silverman, E
    Mouy, R
    Spiegel, L
    Jung, L
    Saurenmann, R
    Lahdenne, P
    Szer, I
    Simpson, K
    Stewart, JA
    Strand, V
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S90 - S90
  • [3] An initial evaluation of the efficacy and safety of leflunomide (LEF) in children with polyarticular course juvenile rheumatoid arthritis (JRA).
    Silverman, E
    Spiegel, L
    Hawkins, D
    Petty, R
    Goldsmith, D
    Schanberg, L
    Duffy, C
    Howard, P
    Desai, K
    Strand, V
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S272 - S272
  • [4] PARENTERAL METHOTREXATE (MTX) FOR JUVENILE RHEUMATOID-ARTHRITIS (JRA)
    SINGSEN, BH
    ROSE, CD
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S137 - S137
  • [5] A clinical and pharmacokinetic (PK) evidence basis for the optimal use of leflunomide (LEF) in pediatric patients with juvenile rheumatoid arthritis (JRA)
    Kovacs, SJ
    Shi, J
    Silverman, E
    Prieur, A
    Simpson, K
    Stewart, J
    Strand, V
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 192 - 192
  • [6] A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis
    Emery, P
    Breedveld, FC
    Lemmel, EM
    Kaltwasser, JP
    Dawes, PT
    Gömör, B
    Van den Bosch, F
    Nordström, D
    Bjorneboe, O
    Dahl, R
    Horslev-Petersen, K
    de la Serna, AR
    Molloy, M
    Tikly, M
    Oed, C
    Rosenburg, R
    Loew-Friedrich, I
    RHEUMATOLOGY, 2000, 39 (06) : 655 - 665
  • [7] THE EFFICACY AND SAFETY OF COMBINATION TREATMENT WITH METHOTREXATE AND LEFLUNOMIDE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS
    Stanislavchuk, M. A.
    Shevchuk, S. V.
    Ursol, N. B.
    RHEUMATOLOGY, 2003, 42 : 97 - 97
  • [8] Treatment of active rheumatoid arthritis (RA) with combination therapy by adding leflunomide (LEF) in patients with an inadeguate response to methotrexate (mtx)
    Pisoni, L
    Schito, E
    De Lucia, O
    Murgo, A
    Zeni, S
    Paresce, E
    Fantini, F
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 457 - 457
  • [9] An observational study of the tolerability and efficacy of leflunomide (LEF) alone and in combination with methotrexate (MTX) in patients with documented resistant rheumatoid arthritis (RA)
    Bingham, Sarah J.
    Buch, Maya
    Lindsay, Stephanie
    Pollard, Alan
    Emery, Paul
    RHEUMATOLOGY, 2001, 40 : 33 - 34
  • [10] Leflunomide (LEF) as initial therapy with methotrexate (MTX) added for rheumatoid
    Cohen, S
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S538 - S539
12345